Paul Tudor Jones's TWST Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 31,109 shares of Twist Bioscience Corporation (TWST) worth $3.2 M, representing 0.00% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in TWST, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 42,674 shares. Largest reduction occurred in Q4 2024, reducing 38,706 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Twist Bioscience Corporation (TWST) Holding Value Over Time
Track share changes against reported price movement
Quarterly Twist Bioscience Corporation (TWST) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +31,109 | New Buy | 31,109 | $102.88 |
| Q4 2025 | -25,465 | Sold Out | 0 | $0.00 |
| Q3 2025 | +25,465 | New Buy | 25,465 | $28.14 |
| Q4 2024 | -38,706 | Sold Out | 0 | $0.00 |
| Q3 2024 | +38,706 | New Buy | 38,706 | $45.18 |
| Q2 2024 | -33,862 | Sold Out | 0 | $0.00 |
| Q1 2024 | -8,812 | Reduce 20.65% | 33,862 | $34.31 |
| Q4 2023 | +42,674 | New Buy | 42,674 | $36.86 |
| Q3 2023 | -28,152 | Sold Out | 0 | $0.00 |
| Q2 2023 | +1,783 | Add 6.76% | 28,152 | $20.46 |
| Q1 2023 | -2,056 | Reduce 7.23% | 26,369 | $0.02 |
| Q4 2022 | +16,626 | Add 140.91% | 28,425 | $0.02 |
| Q3 2022 | +11,799 | New Buy | 11,799 | $35.26 |
| Q2 2022 | -11,186 | Sold Out | 0 | $0.00 |
| Q1 2022 | +76 | Add 0.68% | 11,186 | $49.35 |
| Q4 2021 | +5,256 | Add 89.78% | 11,110 | $77.41 |
| Q3 2021 | +5,854 | New Buy | 5,854 | $106.94 |
| Q2 2021 | -6,543 | Sold Out | 0 | $0.00 |
| Q1 2021 | +6,543 | New Buy | 6,543 | $123.80 |
Paul Tudor Jones's Twist Bioscience Corporation Investment FAQs
Paul Tudor Jones first purchased Twist Bioscience Corporation (TWST) in Q1 2021, acquiring 6,543 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Twist Bioscience Corporation (TWST) for 19 quarters since Q1 2021.
Paul Tudor Jones's largest addition to Twist Bioscience Corporation (TWST) was in Q4 2023, adding 42,674 shares worth $1.57 M.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 31,109 shares of Twist Bioscience Corporation (TWST), valued at approximately $3.2 M.
As of the Q2 2026 filing, Twist Bioscience Corporation (TWST) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Twist Bioscience Corporation (TWST) was 42,674 shares, as reported at the end of Q4 2023.